Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Schmitz

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Journal of Cardiac Failure|October 9, 2012
Genetic variants of the renin-angiotensin-aldosterone system and reverse remodeling after cardiac resynchronization therapyRenata De Maria, Maurizio Landolina, Maurizio Gasparini, et al.
Pharmacogenetics and Genomics|September 30, 2008
Molecular investigation of the functional relevance of missense variants of ICAM-1Peter Vischer, Ralph Telgmann, Boris Schmitz, et al.
Journal of the American Society of Nephrology : JASN|November 3, 2018
Dose-Dependent Effect of Enzyme Replacement Therapy on Neutralizing Antidrug Antibody Titers and Clinical Outcome in Patients with Fabry DiseaseMalte Lenders, Leon Paul Neußer, Michael Rudnicki, et al.
Orphanet Journal of Rare Diseases|May 5, 2016
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variantMalte Lenders, Frank Weidemann, Christine Kurschat, et al.
Internet Interventions|February 26, 2024
Patient-reported preferences in eHealth-based cardiac rehabilitation: A qualitative investigation of behavior change techniques, barriers and facilitatorsEmma R Douma, Svenja Wirtz, Manuela Sestayo Fernandez, et al.
Frontiers in Nutrition|November 10, 2025
Biomarker-based risk assessment of dietary intervention in patients with coronary artery disease during cardiac rehabilitation-a quasi-experimental studyMona Kotewitsch, Hubert Scharnagl, Dennis Köstler, et al.
Journal of Medical Internet Research|February 22, 2024
Living Lab Data of Patient Needs and Expectations for eHealth-Based Cardiac Rehabilitation in Germany and Spain From the TIMELY Study: Cross-Sectional AnalysisBoris Schmitz, Svenja Wirtz, Manuela Sestayo-Fernández, et al.
Atherosclerosis|October 1, 2013
Increased monocyte adhesion by endothelial expression of VCAM-1 missense variation in vitroBoris Schmitz, Peter Vischer, Eva Brand, et al.
Circulation. Cardiovascular Genetics|September 12, 2014
Identification of genetic markers for treatment success in heart failure patients: insight from cardiac resynchronization therapyBoris Schmitz, Renata De Maria, Dimitris Gatsios, et al.
JMIR Research Protocols|August 14, 2025
Patient-Centered Risk Prediction, Prevention, and Intervention Platform (TIMELY) to Support the Continuum of Care in Coronary Artery Disease Using eHealth and Artificial Intelligence: Protocol for a Randomized Controlled TrialMirela Habibovic, Emma Douma, Hendrik Schäfer, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Journal of Cardiac Failure|October 9, 2012
Genetic variants of the renin-angiotensin-aldosterone system and reverse remodeling after cardiac resynchronization therapyRenata De Maria, Maurizio Landolina, Maurizio Gasparini, et al.
Pharmacogenetics and Genomics|September 30, 2008
Molecular investigation of the functional relevance of missense variants of ICAM-1Peter Vischer, Ralph Telgmann, Boris Schmitz, et al.
Journal of the American Society of Nephrology : JASN|November 3, 2018
Dose-Dependent Effect of Enzyme Replacement Therapy on Neutralizing Antidrug Antibody Titers and Clinical Outcome in Patients with Fabry DiseaseMalte Lenders, Leon Paul Neußer, Michael Rudnicki, et al.
Orphanet Journal of Rare Diseases|May 5, 2016
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variantMalte Lenders, Frank Weidemann, Christine Kurschat, et al.
Internet Interventions|February 26, 2024
Patient-reported preferences in eHealth-based cardiac rehabilitation: A qualitative investigation of behavior change techniques, barriers and facilitatorsEmma R Douma, Svenja Wirtz, Manuela Sestayo Fernandez, et al.
Frontiers in Nutrition|November 10, 2025
Biomarker-based risk assessment of dietary intervention in patients with coronary artery disease during cardiac rehabilitation-a quasi-experimental studyMona Kotewitsch, Hubert Scharnagl, Dennis Köstler, et al.
Journal of Medical Internet Research|February 22, 2024
Living Lab Data of Patient Needs and Expectations for eHealth-Based Cardiac Rehabilitation in Germany and Spain From the TIMELY Study: Cross-Sectional AnalysisBoris Schmitz, Svenja Wirtz, Manuela Sestayo-Fernández, et al.
Atherosclerosis|October 1, 2013
Increased monocyte adhesion by endothelial expression of VCAM-1 missense variation in vitroBoris Schmitz, Peter Vischer, Eva Brand, et al.
Circulation. Cardiovascular Genetics|September 12, 2014
Identification of genetic markers for treatment success in heart failure patients: insight from cardiac resynchronization therapyBoris Schmitz, Renata De Maria, Dimitris Gatsios, et al.
JMIR Research Protocols|August 14, 2025
Patient-Centered Risk Prediction, Prevention, and Intervention Platform (TIMELY) to Support the Continuum of Care in Coronary Artery Disease Using eHealth and Artificial Intelligence: Protocol for a Randomized Controlled TrialMirela Habibovic, Emma Douma, Hendrik Schäfer, et al.
Pageof 9